nivolumab,rigosertib
onconova therapeutics,SymBio pharmaceuticals,Knight Therapeutics,bms
['rigoser', 'nivo', 'lung', 'nivolumab', 'onconova therapeutics']
onconova therapeutics therapeutics announces updated data from investigator-sponsored phase 1/2a trial evaluating rigosertib in combination with nivolumab in advanced kras-mutated non-small cell lung cancer at the esmo congress 2022 
onconova therapeutics (NASDAQ: ONTX) is clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for patients with cancer.